Acetyl-CoA carboxylase (ACC)

  • 文章类型: Journal Article
    肺炎链球菌是社区获得性肺炎的主要原因,是急性侵入性和非侵入性感染的原因。目前,疫苗覆盖率不足和抗菌素耐药性上升阻碍了与肺炎球菌的斗争。使新药靶点的研究成为必要。高通量诱变表明,乙酰辅酶A羧化酶(ACC)是肺炎链球菌中的必需酶,可将乙酰辅酶A转化为丙二酰辅酶A,脂肪酸生物合成的关键步骤。ACC有四个亚基;生物素羧基载体蛋白(BCCP),生物素羧化酶(BC),羧基转移酶亚基α和β。激活ACC复合物需要肺炎链球菌BCCP(SpBCCP)的生物素化。在这项研究中,我们已经对SpBCCP80的apo-和全-生物素化结构域进行了生物物理表征。我们进行了2D和3DNMR实验,以分析SpBCCP80生物素化后氨基酸残基的变化。Further,我们使用NMR主链化学位移分配数据进行生物信息学分析,以确定蛋白质的二级和三级结构。我们观察到生物素化后AMKVM基序和SpBCCP80拇指区的主要变化。总的来说,这项工作提供了对SpBCCP80的全转换的结构见解,SpBCCP80可进一步用作抗肺炎链球菌的药物靶标.
    Streptococcus pneumoniae is a leading cause of community-acquired pneumonia and is responsible for acute invasive and non-invasive infections. Fight against pneumococcus is currently hampered by insufficient vaccine coverage and rising antimicrobial resistance, making the research necessary on novel drug targets. High-throughput mutagenesis has shown that acetyl-CoA carboxylase (ACC) is an essential enzyme in S. pneumoniae which converts acetyl-CoA to malonyl-CoA, a key step in fatty acid biosynthesis. ACC has four subunits; Biotin carboxyl carrier protein (BCCP), Biotin carboxylase (BC), Carboxyl transferase subunit α and β. Biotinylation of S. pneumoniae BCCP (SpBCCP) is required for the activation of ACC complex. In this study, we have biophysically characterized the apo- and holo- biotinylating domain SpBCCP80. We have performed 2D and 3D NMR experiments to analyze the changes in amino acid residues upon biotinylation of SpBCCP80. Further, we used NMR backbone chemical shift assignment data for bioinformatical analyses to determine the secondary and tertiary structure of proteins. We observed major changes in AMKVM motif and thumb region of SpBCCP80 upon biotinylation. Overall, this work provides structural insight into the apo- to holo- conversion of SpBCCP80 which can be further used as a drug target against S. pneumoniae.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    Glinusoppositifolius是一种在热带亚洲国家发现的特有草本植物,原产于越南。由于其风味,防腐和通便作用,因此被用于传统民间医学。在目前的研究中,Tox-off的影响,Biovip,并对先前研究中分离出的纯化化合物对C2C12成肌细胞中腺苷5'-单磷酸活化蛋白激酶(AMPK)活化蛋白激酶(AMPK)和乙酰辅酶A羧化酶(ACC)的活化进行了评估。此外,最有效的活性化合物,天花苷-GO1(TRA-GO1)和TRA-GO5验证了HepG2细胞中脂肪酸合成酶(FAS)和固醇调节元件结合蛋白(SREBP)-1c的降低。我们发现Tox-off和Biovip显着增加C2C12成肌细胞中AMPK和ACC的磷酸化。此外,与二甲基亚砜(DMSO)对照相比,TRA-GO1和TRA-GO5以浓度依赖性方式显著增加其下游底物ACC的AMPK活化和磷酸化。此外,TRA-GO1和TRA-GO5以浓度依赖性方式降低FAS和SREBP-1c的蛋白水平。一起来看,我们的结果表明,通过G的活性成分增加的AMPK和ACC磷酸化可以激活AMPK信号通路,这对于抗肥胖及其相关的代谢紊乱是有用的。
    Glinus oppositifolius is an endemic herbaceous plant found in tropical Asian countries and is native in Vietnam. It is used in traditional folk medicine because of its flavor and antiseptic and laxative effects. In the current research, the effects of Tox-off, Biovip, and the purified compounds isolated from G. oppositifolius in the previous study were evaluated on the activation of adenosine 5\'-monophosphate-activated protein kinase (AMPK)-activated protein kinase (AMPK) and acetyl-coenzyme A carboxylase (ACC) in C2C12 myoblasts. In addition, the most potent active compounds, traphanoside-GO1 (TRA-GO1) and TRA-GO5 have validated the reduction of fatty acid synthase (FAS) and sterol regulatory element binding protein (SREBP)-1c in HepG2 cells. We found that Tox-off and Biovip significantly increased the phosphorylation of AMPK and ACC in C2C12 myoblasts. Furthermore, TRA-GO1 and TRA-GO5 significantly increased the AMPK activation and phosphorylation of its downstream substrate ACC in a concentration-dependent way compared to the dimethyl sulfoxide (DMSO) control. Besides, the protein level of FAS and SREBP-1c decreased by TRA-GO1 and TRA-GO5 in a concentration-dependent manner. Taken together, our results showed that the increased AMPK and ACC phosphorylation by active components of G. oppositifolius may activate the AMPK signaling pathways, which are useful for the anti-obesity and its related metabolic disorders.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    红景天是一种食血昆虫,南美锥虫病的媒介。喂食后,随着血液慢慢消化,氨基酸被用作燃料脂质合成的底物,成年雌性在脂肪体内积累脂质并产生卵。为了评估从头合成脂肪酸对这种昆虫代谢的重要性,我们产生了乙酰辅酶A羧化酶(ACC)缺陷型昆虫。击倒(AccKD)雌性的血液消化延迟,寿命较短。他们的脂肪体显示从头脂肪生成活性降低,在血餐后的几天内没有积累三酰甘油,并有较小的脂滴。喂食后10天,脂肪体内中性脂质和磷脂的含量普遍减少。血淋巴里,在血餐后5天观察到脂质成分没有差异,但是在第十天,碳氢化合物含量增加,磷脂减少。总蛋白浓度和氨基酸组成不受影响。AccKD雌性产卵比对照组少60%,只有7%的人孵化(89%的人是对照组),尽管它们的总蛋白和三酰甘油含量没有差异。卵表面的扫描电子显微镜显示,与对照相比,AccKD昆虫产下的卵的绒毛膜(蛋壳)的超微结构模式发生了变化。这些结果表明,ACC在R.prolixus营养稳态中起着核心作用,其适当的活性对消化很重要,脂质合成和储存,和生殖成功。
    Rhodnius prolixus is a hematophagous insect, vector of Chagas disease. After feeding, as blood is slowly digested, amino acids are used as substrates to fuel lipid synthesis, and adult females accumulate lipids in the fat body and produce eggs. In order to evaluate the importance of de novo fatty acid synthesis for this insect metabolism, we generated acetyl-CoA carboxylase (ACC) deficient insects. The knockdown (AccKD) females had delayed blood digestion and a shorter lifespan. Their fat bodies showed reduced de novo lipogenesis activity, did not accumulate triacylglycerol during the days after blood meal, and had smaller lipid droplets. At 10 days after feeding, there was a general decrease in the amounts of neutral lipids and phospholipids in the fat body. In the hemolymph, no difference was observed in lipid composition at 5 days after blood meal, but at day ten, there was an increase in hydrocarbon content and a decrease in phospholipids. Total protein concentration and amino acid composition were not affected. The AccKD females laid 60% fewer eggs than the control ones, and only 7% hatched (89% for control), although their total protein and triacylglycerol contents were not different. Scanning electron microscopy of the egg surface showed that chorion (eggshell) from the eggs laid by the AccKD insects had an altered ultrastructural pattern when compared to control ones. These results show that ACC has a central role in R. prolixus nutrient homeostasis, and its appropriate activity is important to digestion, lipid synthesis and storage, and reproductive success.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    肥胖促进骨关节炎(OA)的发展。它也是公认的肥胖导致过度的脂质沉积在非脂肪组织,经常引起脂毒性。这项研究的目的是研究肥胖情况下小鼠软骨中各种脂质水平的变化,并确定软骨细胞从头脂肪生成是否改变。我们使用油红O来确定高脂饮食(HFD)或低脂饮食(LFD)的小鼠软骨中脂质滴的积累。我们进一步使用基于质谱的脂质组学分析来量化不同脂质种类的水平。参与脂肪酸(FA)摄取的基因的表达,合成,伸长率,使用定量聚合酶链反应检查去饱和。为了进一步研究潜在的机制,我们在高糖和高胰岛素条件下培养原代小鼠软骨细胞,以模拟与肥胖相关的局部微环境,随后检测细胞脂滴的丰度.乙酰辅酶A羧化酶(ACC)抑制剂,将ND-630加入到培养基中,以检查抑制从头脂肪生成对软骨细胞中脂质积累的影响。与接受LFD的小鼠相比,HFD组显示更多的软骨细胞具有可见的细胞内脂滴。在HFD组中还检测到显著较高量的总FA。六个显著上调的FA中有五个是ω-6FA,而两个显著下调的FAs是ω-3FAs。因此,HFD组显示出显著较高的ω-6/ω-3FA比率。还发现醚连接的磷脂酰胆碱在HFD组中较高。脂肪酸去饱和酶(Fad1-3),脂肪酸结合蛋白4(Fabp4),和脂肪酸合酶(Fasn)转录本在治疗组之间没有发现差异,并且脂肪酸延伸酶(Elovl1-7)转录本在软骨中检测不到。神经酰胺合酶2(Cers-2),在这些研究中发现的唯一被改变的转录本,在HFD组中显著上调。体外,软骨细胞在高葡萄糖下培养时上调从头脂肪生成,高胰岛素条件,这个观察结果与ACC的激活有关,通过添加ND-630而减弱。这项研究提供了第一个证据,表明肥胖软骨中脂质沉积增加,这与ACC介导的从头脂肪生成的上调有关。我们的观察结果支持了ACC抑制改善软骨细胞中的脂质积累,因此表明ACC可能有针对性地治疗肥胖相关的OA。
    Obesity promotes the development of osteoarthritis (OA). It is also well-established that obesity leads to excessive lipid deposition in nonadipose tissues, which often induces lipotoxicity. The objective of this study was to investigate changes in the levels of various lipids in mouse cartilage in the context of obesity and determine if chondrocyte de novo lipogenesis is altered. We used Oil Red O to determine the accumulation of lipid droplets in cartilage from mice fed high-fat diet (HFD) or low-fat diet (LFD). We further used mass spectrometry-based lipidomic analyses to quantify levels of different lipid species. Expression of genes involving in fatty acid (FA) uptake, synthesis, elongation, and desaturation were examined using quantitative polymerase chain reaction. To further study the potential mechanisms, we cultured primary mouse chondrocytes under high-glucose and high-insulin conditions to mimic the local microenvironment associated with obesity and subsequently examined the abundance of cellular lipid droplets. The acetyl-CoA carboxylase (ACC) inhibitor, ND-630, was added to the culture medium to examine the effect of inhibiting de novo lipogenesis on lipid accumulation in chondrocytes. When compared to the mice receiving LFD, the HFD group displayed more chondrocytes with visible intracellular lipid droplets. Significantly higher amounts of total FAs were also detected in the HFD group. Five out of six significantly upregulated FAs were ω-6 FAs, while the two significantly downregulated FAs were ω-3 FAs. Consequently, the HFD group displayed a significantly higher ω-6/ω-3 FA ratio. Ether linked phosphatidylcholine was also found to be higher in the HFD group. Fatty acid desaturase (Fad1-3), fatty acid-binding protein 4 (Fabp4), and fatty acid synthase (Fasn) transcripts were not found to be different between the treatment groups and fatty acid elongase (Elovl1-7) transcripts were undetectable in cartilage. Ceramide synthase 2 (Cers-2), the only transcript found to be changed in these studies, was significantly upregulated in the HFD group. In vitro, chondrocytes upregulated de novo lipogenesis when cultured under high-glucose, high-insulin conditions, and this observation was associated with the activation of ACC, which was attenuated by the addition of ND-630. This study provides the first evidence that lipid deposition is increased in cartilage with obesity and that this is associated with the upregulation of ACC-mediated de novo lipogenesis. This was supported by our observation that ACC inhibition ameliorated lipid accumulation in chondrocytes, thereby suggesting that ACC could potentially be targeted to treat obesity-associated OA.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    AMP激活的激酶(AMPK)信号通路在心肌缺血期间被激活并促进心脏脂肪酸(FA)摄取和氧化。同样,多功能Ca2+/钙调蛋白依赖性蛋白激酶II(CaMKII)也是由心肌缺血触发的,但其在FA代谢中的功能尚不清楚。这里,我们通过研究心脏CaMKII对AMPK-乙酰辅酶A羧化酶(ACC)的影响,探讨了CaMKII在心肌缺血时FA代谢中的作用,丙二酰辅酶A脱羧酶(MCD),和FA转位酶分化簇36(FAT/CD36),以及心脏FA的摄取和氧化。此外,我们检测了CaMKII和AMPK是否为结合伴侣.我们证明晚期缺血性心脏病患者的患病心脏显示CaMKII磷酸化增加,AMPK,和ACC以及MCD和FAT/CD36的表达增加。AC3-I小鼠,对CaMKII有遗传性心肌抑制作用,心脏AMPK基因表达降低。在MI后(心肌梗死)AC3-I心脏中,AMPK-ACC磷酸化,MCD和FAT/CD36水平,心脏FA摄取,和FA氧化显著降低。值得注意的是,我们证明CaMKII与心脏中的AMPKα1和α2亚基相互作用。此外,AC3-I小鼠在MI后2周表现出明显较少的心脏肥大和细胞凋亡。总的来说,这些发现揭示了CaMKII抑制通过与AMPK信号通路相互作用抑制FA代谢的独特作用,这可能代表了缺血性心脏病的一种新机制。
    An AMP-activated kinase (AMPK) signaling pathway is activated during myocardial ischemia and promotes cardiac fatty acid (FA) uptake and oxidation. Similarly, the multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII) is also triggered by myocardial ischemia, but its function in FA metabolism remains unclear. Here, we explored the role of CaMKII in FA metabolism during myocardial ischemia by investigating the effects of cardiac CaMKII on AMPK-acetyl-CoA carboxylase (ACC), malonyl CoA decarboxylase (MCD), and FA translocase cluster of differentiation 36 (FAT/CD36), as well as cardiac FA uptake and oxidation. Moreover, we tested whether CaMKII and AMPK are binding partners. We demonstrated that diseased hearts from patients with terminal ischemic heart disease displayed increased phosphorylation of CaMKII, AMPK, and ACC and increased expression of MCD and FAT/CD36. AC3-I mice, which have a genetic myocardial inhibition of CaMKII, had reduced gene expression of cardiac AMPK. In post-MI (myocardial infarction) AC3-I hearts, AMPK-ACC phosphorylation, MCD and FAT/CD36 levels, cardiac FA uptake, and FA oxidation were significantly decreased. Notably, we demonstrated that CaMKII interacted with AMPK α1 and α2 subunits in the heart. Additionally, AC3-I mice displayed significantly less cardiac hypertrophy and apoptosis 2 weeks post-MI. Overall, these findings reveal a unique role for CaMKII inhibition in repressing FA metabolism by interacting with AMPK signaling pathways, which may represent a novel mechanism in ischemic heart disease.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    Edible insects, Bombyx mori (silkworm; SW), which feed on mulberry leaves, have been consumed by humans for a long time as supplements or traditional medication. Non-alcoholic fatty liver disease (NAFLD) is a liver metabolic disorder that affects many people worldwide. We examined the hepatoprotective effects of SW using in vitro and high-fat and high-fructose (HFHF) diet-induced obese in vivo model mice by real-time PCR, immunoblot analysis, and fecal microbiota analysis. SW significantly reduced lipid accumulation and expression of the lipogenic genes in HepG2 cells and the livers of HFHF-induced mice. SW caused significant reductions in triglycerides, and total cholesterol in serum and upregulation of fatty acid oxidation markers compared to the HFHF group. Besides, SW significantly induced phosphorylation of AMPK and ACC in both models, suggesting roles in AMPK activation and the ACC signaling pathway. Furthermore, the gut microbiota analysis demonstrated that SW treatment reduced Firmicutes to Bacteroidetes ratios and the relative abundance of the Lachnospiraceae family compared to HFHF-induced obese mice. These results provide a novel therapeutic agent of hepatoprotective effects of SW for non-alcoholic hepatic steatosis that targets hepatic AMPK and ACC-mediated lipid metabolism.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

  • 文章类型: Journal Article
    Both berberine and metformin are well-known antihyperglycemic agents for diabetes treatment. Adenosine monophosphate (AMP)-activated protein kinase (AMPK) activation is often considered as the most important molecular mechanism although the mechanism has been challenged recently. Up to now, when the ambient glucose level changes dynamically, the interaction between AMPK activity and the glucose-lowering effects of the agents remains largely unknown. To address this issue, HepG2 hepatocytes and C2C12 myotubes were preincubated at normal (5.6 mM), moderate (15 mM), or high (30 mM) glucose concentrations followed by moderate-glucose incubation plus berberine or metformin treatment. Preincubation at high glucose concentration followed by moderate-glucose incubation activated the AMPK pathway, but the activation was abolished with berberine or metformin treatment. In contrast, alteration from normal glucose to moderate glucose concentration in the medium suppressed AMPK activity, which was activated by berberine or metformin. Both metformin and berberine decreased the intercellular adenosine triphosphate content, enhanced glucose consumption, and lactate release under all three preincubation glucose concentrations regardless of AMPK activity. In conclusion, AMPK activated by glucose reduction is inhibited by berberine or metformin. The elevation of glucose level led to suppressed AMPK activity, which was activated with the addition of agents. The potent glucose-lowering effects with minimal hypoglycemia of berberine and metformin may be partially due to their bidirectional regulation of the AMPK signaling pathway. Berberine and metformin promote glucose metabolism via stimulation of glycolysis, which may not be related to AMPK activity.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    Previous investigations on diabetic rats and palmitic corrosive instigated insulin-resistant HepG2 cells have shown that polydatin exhibits hypoglycemic and hypolipidemic impacts. The AMP-activated protein kinase (AMPK) pathway assumes a crucial part in glucose and lipid digestion. We aimed to investigate the regulatory system of polydatin on the glucose and lipid metabolism through the AMPK pathway. Glucose take-up, utilization levels, and oil red O recoloring were distinguished to confirm their impact on improving insulin resistance. A Western blot examination was utilized to investigate the phosphorylation levels of protein kinase B (Akt), glycogen synthase kinase (GSK)-3β, AMPK, acetyl-CoA carboxylase (ACC), and in addition the protein levels of the low-density lipoprotein receptor (LDLR) and sterol regulatory element-binding protein (SREBP)-1c. SREBP-1c nuclear translocation levels were recognized by a laser checking confocal magnifying instrument. One hundred nanomolar insulin treated for 24 h significantly declined the phosphorylation of Akt and AMPK, and increased the nucleoproteins of SREBP-1c compared with HepG2 cells without insulin. The insulin-resistant HepG2 cells prompted by insulin mediated the impact of polydatin on glucose and lipid digestion. Polydatin decreased glucose and lipid digestion of insulin-resistant HepG2 cells. Moreover, polydatin markedly raised phosphorylated Akt, GSK-3β, AMPK, ACC, diminished nuclear protein levels of SREBP-1c, and upgraded the protein levels of LDLR. Regulation of the AMPK pathway and changes in LDLR protein expression are potential focuses of polydatin in the treatment of insulin protection in insulin-resistant HepG2 cells.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    Our previous work showed that geniposide affected glucose-stimulated insulin secretion (GSIS) via regulating glucose uptake and metabolism in pancreatic β cells; however, the molecular mechanisms remain largely unknown. Substantial evidence suggests that activation of 5\'-AMP-activated protein kinase (AMPK) plays a central role in GSIS. Here, we aim to determine the role of AMPK on geniposide-regulated GSIS in rat pancreatic INS-1 cells. The results demonstrated that 6-[4-(2-piperidin-1-yletoxy)-phenyl]-3-pyridin-4-yl-pyrazolo[1,5-α] pyrimidine (Compound C; an AMPK inhibitor) significantly attenuated the effects of geniposide on glucose uptake, energy metabolism, and insulin secretion in INS-1 cells. We also observed that geniposide induced phosphorylation of acetyl-CoA carboxylase (ACC), a marker of AMPK activity, in a time-dependent manner in INS-1 cells; however, in the presence of Compound C, the influence of geniposide on ACC phosphorylation was obviously inhibited. Furthermore, the knockdown of AMPK protein with AMPK siRNA treatment decreased the effects of geniposide on glucose uptake, adenosine triphosphate production, and GSIS. All these data indicate that AMPK plays an essential role in geniposide-regulated GSIS in pancreatic β cells.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

  • 文章类型: Journal Article
    Aspirin, the pro-drug of salicylate, is associated with reduced incidence of death from cancers of the colon, lung and prostate and is commonly prescribed in combination with metformin in individuals with type 2 diabetes. Salicylate activates the AMP-activated protein kinase (AMPK) by binding at the A-769662 drug binding site on the AMPK β1-subunit, a mechanism that is distinct from metformin which disrupts the adenylate charge of the cell. A hallmark of many cancers is high rates of fatty acid synthesis and AMPK inhibits this pathway through phosphorylation of acetyl-CoA carboxylase (ACC). It is currently unknown whether targeting the AMPK-ACC-lipogenic pathway using salicylate and/or metformin may be effective for inhibiting cancer cell survival. Salicylate suppresses clonogenic survival of prostate and lung cancer cells at therapeutic concentrations achievable following the ingestion of aspirin (<1.0 mM); effects not observed in prostate (PNT1A) and lung (MRC-5) epithelial cell lines. Salicylate concentrations of 1 mM increased the phosphorylation of ACC and suppressed de novo lipogenesis and these effects were enhanced with the addition of clinical concentrations of metformin (100 μM) and eliminated in mouse embryonic fibroblasts (MEFs) deficient in AMPK β1. Supplementation of media with fatty acids and/or cholesterol reverses the suppressive effects of salicylate and metformin on cell survival indicating the inhibition of de novo lipogenesis is probably important. Pre-clinical studies evaluating the use of salicylate based drugs alone and in combination with metformin to inhibit de novo lipogenesis and the survival of prostate and lung cancers are warranted.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

公众号